Global Hepatitis B Vaccines Market Size, Analysis, Share, Research, Growth, Trends, Report, Opportunities and Forecast 2014-2018 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Global Hepatitis B Vaccines Market Size, Analysis, Share, Research, Growth, Trends, Report, Opportunities and Forecast 2014-2018

Description:

About Hepatitis B Vaccines Hepatitis B is an inflammatory condition that occurs due to infection by hepatitis B virus. Hepatitis B virus is an enveloped virus that belongs to the family of hepadnavirus. It contains a circular genome with partially double-stranded DNA. The virus interferes with the normal functioning of the liver cells. Following the viral infection, the immune system is activated against virus and hepatocytes infected with viruses. This, in turn, leads to the inflammation of the liver. Extra-hepatic manifestations of hepatitis B include polyarteritis nodosa, Gianotti-Crosti syndrome. Get full access of the report at: – PowerPoint PPT presentation

Number of Views:31

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Hepatitis B Vaccines Market Size, Analysis, Share, Research, Growth, Trends, Report, Opportunities and Forecast 2014-2018


1
Global Hepatitis B Vaccines Market 2014-2018
Publish By Technovia
Email sales_at_researchbeam.com
Toll Free 1 (855) 711-1555
2
Report Overview
About Hepatitis B Vaccines Hepatitis B is an
inflammatory condition that occurs due to
infection by hepatitis B virus. Hepatitis B virus
is an enveloped virus that belongs to the family
of hepadnavirus. It contains a circular genome
with partially double-stranded DNA. The virus
interferes with the normal functioning of the
liver cells. Following the viral infection, the
immune system is activated against virus and
hepatocytes infected with viruses. This, in turn,
leads to the inflammation of the liver.
Extra-hepatic manifestations of hepatitis B
include polyarteritis nodosa, Gianotti-Crosti
syndrome, transient serum sickness-like syndrome,
and membranous glomerulonephritis. Perinatal
transmission of hepatitis B virus is the most
common mode of infection spread. Age of a person
at the time of infection and infecting dose of
virus are important factors that determine the
severity of acute or chronic hepatitis B. Most of
the patients suffering from acute hepatitis B
recover spontaneously without significant
consequences. The chronic form of infection, in
some cases, can progress up to cirrhosis and
liver cancer. Hepatitis B infection can be
prevented by immunization with hepatitis B
vaccines. TechNavio's analysts forecast the
Global Hepatitis B Vaccines market to grow at a
CAGR of 4.00 percent over the period 2013-2018.
3
Report Overview
Key Regions Americas APAC EMEA Key
Vendors GlaxoSmithKline Merck Sanofi
Pasteur Other Prominent Vendors Dynavax
Technologies Janssen Pharmaceuticals LG Life
Sciences Kaketsuken Shenzhen Kangtai
Biological Products Market Driver Increased
Awareness about Hepatitis B Infection and
Prevention For a full, detailed list, view our
report Get full access of the report at
http//www.researchbeam.com/global-hepatitis-b-vac
cines-2014-2018-market
4
Report Overview
Market Challenge Inadequate Vaccine Coverage
For a full, detailed list, view our
report Market Trend Combination Vaccines For
a full, detailed list, view our report Key
Questions Answered in this Report What will the
market size be in 2018 and what will the growth
rate be? What are the key market trends? What
is driving this market? What are the challenges
to market growth? Who are the key vendors in
this market space? What are the market
opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?
5
Table Of Content
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 03.1
Market Overview 03.2 Product Offerings 04.
Market Research Methodology 04.1 Market Research
Process 04.2 Research Methodology 05. Disease
Overview 05.1 Hepatitis B Acute and Chronic
Infection
6
Table Of Content
05.2 Hepatitis B Geographical Distribution 05.3
Hepatitis B Estimated National Immunization
Coverage 05.3.1 Hepatitis B Birth Dose
Vaccine 05.3.2 Third Dose of Hepatitis B
Vaccine 05.4 Chronic Disease Prone Individuals
for Hepatitis B 05.5 Hepatitis B
Diagnosis 05.5.1 Serological Markers 05.5.2
Hepatitis B Serologic Test Interpretation 06.
Introduction 07. Market Landscape
7
List of Exhibits
Exhibit 1 Market Research Methodology Exhibit
2 Pathway of Hepatitis B Progression Exhibit 3
Number of Hepatitis B Birth Doses Administered in
WHO Regions Exhibit 4 Trend of Hepatitis B
Birth Doses Administered in WHO Regions
2000-2013 Exhibit 5 Percentage Share of
Different Regions in 2013 Exhibit 6 Number of
Third Doses of Hepatitis B Administered in WHO
Regions Exhibit 7 Trend of Third Doses of
Hepatitis B Administered in WHO Regions
2000-2013 Exhibit 8 Percentage Share of
Different Regions in 2013 Exhibit 9 Comparison
of Third Dose and Birth Dose in 2013 in WHO
Regions Exhibit 10 Disease Progression of
Hepatitis B
8
List of Exhibits
Exhibit 11 Significance of Serological
Markers Exhibit 12 Interpretation of
Serological Markers Exhibit 13 Global Hepatitis
B Vaccines Market 2013-2018 (US
million) Exhibit 14 Global Hepatitis B Vaccines
Market Segmentation by Composition Exhibit 15
Dosage Regimen of Engerix-B Exhibit 16 Dosage
Regimen of Fendrix Exhibit 17 Dosage Regimen of
Recombivax HB Exhibit 18 Dosage Regimen of
Infanrix hexa To make an enquiry before
purchasing the report, visit at
http//www.researchbeam.com/global-hepatitis-b-vac
cines-2014-2018-market/purchase-enquiry
9
Contact Us
Direct 1 (617) 674-4143 Toll Free 1 (855)
711-1555 Fax 1 (855) 550-5975 Web
www.researchbeam.com Email sales_at_researchbeam.com
Deep 5320 SW Macadam Avenue, Suite 100,
Portland, OR 97239 United States
About PowerShow.com